Works by Kim, Nam Hoon


Results: 241
    1
    2
    3
    4
    5
    6
    7
    8

    Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐label, active‐controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3642, doi. 10.1111/dom.15705
    By:
    • Kim, Nam Hoon;
    • Moon, Jun Sung;
    • Lee, Yong‐ho;
    • Cho, Ho Chan;
    • Kwak, Soo Heon;
    • Lim, Soo;
    • Moon, Min Kyong;
    • Kim, Dong‐Lim;
    • Kim, Tae Ho;
    • Ko, Eunvin;
    • Lee, Juneyoung;
    • Kim, Sin Gon
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

    Published in:
    Endocrinology & Metabolism, 2024, v. 39, n. 5, p. 722, doi. 10.3803/EnM.2024.1995
    By:
    • Nam Hoon Kim;
    • Juneyoung Lee;
    • Suk Chon;
    • Jae Myung Yu;
    • In-Kyung Jeong;
    • Soo Lim;
    • Won Jun Kim;
    • Keeho Song;
    • Ho Chan Cho;
    • Hea Min Yu;
    • Kyoung-Ah Kim;
    • Sang Soo Kim;
    • Soon Hee Lee;
    • Chong Hwa Kim;
    • Soo Heon Kwak;
    • Yong‐ho Lee;
    • Choon Hee Chung;
    • Sihoon Lee;
    • Heung Yong Jin;
    • Jae Hyuk Lee
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Diabetes Fact Sheets in Korea 2024.

    Published in:
    Diabetes & Metabolism Journal, 2025, v. 49, n. 1, p. 24, doi. 10.4093/dmj.2024.0818
    By:
    • Se Eun Park;
    • Seung-Hyun Ko;
    • Ji Yoon Kim;
    • Kyuho Kim;
    • Joon Ho Moon;
    • Nam Hoon Kim;
    • Kyung Do Han;
    • Sung Hee Choi;
    • Bong Soo Cha
    Publication type:
    Article
    43
    44

    2023 Diabetic Kidney Disease Fact Sheet in Korea.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 3, p. 463, doi. 10.4093/dmj.2023.0310
    By:
    • Nam Hoon Kim;
    • Mi-Hae Seo;
    • Jin Hyung Jung;
    • Kyung Do Han;
    • Mi Kyung Kim;
    • Nan Hee Kim
    Publication type:
    Article
    45

    Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 2, p. 279, doi. 10.4093/dmj.2023.0225
    By:
    • Ye Seul Yang;
    • Nam Hoon Kim;
    • Jong Ha Baek;
    • Seung-Hyun Ko;
    • Jang Won Son;
    • Seung-Hwan Lee;
    • Sang Youl Rhee;
    • Soo-Kyung Kim;
    • Tae Seo Sohn;
    • Ji Eun Jun;
    • In-Kyung Jeong;
    • Chong Hwa Kim;
    • Keeho Song;
    • Eun-Jung Rhee;
    • Junghyun Noh;
    • Kyu Yeon Hur
    Publication type:
    Article
    46
    47
    48
    49

    The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

    Published in:
    Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 818, doi. 10.4093/dmj.2023.0171
    By:
    • Jun Sung Moon;
    • Il Rae Park;
    • Sang Soo Kim;
    • Hye Soon Kim;
    • Nam Hoon Kim;
    • Sin Gon Kim;
    • Seung Hyun Ko;
    • Ji Hyun Lee;
    • Inkyu Lee;
    • Bo Kyeong Lee;
    • Kyu Chang Won
    Publication type:
    Article
    50